Skip to main content
Asian Pacific Journal of Cancer Prevention : APJCP logoLink to Asian Pacific Journal of Cancer Prevention : APJCP
. 2025;26(6):2071–2077. doi: 10.31557/APJCP.2025.26.6.2071

The Anticancer Effect of Haematococcus Pluvialis Alga Extract on Breast Cancer Cell Line

Vahideh Shamskhani 1, Habib Zarredar 2, Jafar Razeghi 1, Atefeh Ansarin 2, Milad Asadi 3, Zahra Soleimani 4, Ensiyeh Seyedrezazadeh 2,*
PMCID: PMC12374507  PMID: 40542769

Abstract

Objective:

The aim of this study was to investigate the anticancer effects of H. pluvialis extract on breast cancer.

Methods:

We evaluated the cytotoxicity, suppression of migration, and apoptosis ability of H. pluvialis alga extract MDA-MB-468 by MTT assay, scratch test, and flow cytometry, respectively. The expression patterns of MMP1 and MMP9, Bax and Bcl2, Caspase3, Caspase6, and Caspase9 were analyzed by qRT-PCR.

Results:

Based on the findings of this study, the survival and proliferation capacity of MDA-MB-468 cells treated with the extract was reduced. Flow cytometry results showed that treatment with H. Pluvialis extracts induced apoptosis. Scratch test results showed that H. Pluvialis extract could inhibit cell migration. The expression patterns of the studied genes were changed by treatment with the extract. Expression of Bcl2, MMP1, and MMP9 genes decreased, and expression of Bax, Caspase3, Caspase8, Caspase9 genes increased.

Conclusion:

The findings of this research reveal that H. pluvialis algae extract shows a potential anti-cancer compound.

Key Words: Breast cancer, Haematococcus Pluvialis, Cell migration, Apoptosis

Introduction

Despite recent advancements in cancer diagnosis and treatments globally, According to statistics provided by the International Agency for Research on Cancer, breast cancer is the main concern of women and the most common type of cancer among them. Most women with breast cancer are over 45 years old, and younger women can also implicated [1, 2]. It is the leading cause of cancer among Iranian women, accounting for 27% of all malignancies in women [3]. Breast cancer is a potentially aggressive disease with highly heterogeneous molecular mechanisms that lifestyle and environmental factors including high-fat diet, obesity, shift work factors, smoking, antiperspirants, breast Implants, alcohol consumption, lack of physical exercise, hormone replacement therapy, ionizing radiation influence its progression [4]. Approximately 5 to 10% of breast cancers occur inherited with the BRCA1 and BRCA2 genes playing the most important role. These genes are involved in repairing damaged DNA are sometimes called tumor suppressor genes and when they have certain changes, pathogenic variants, or mutations, cancer can develop [5, 6]. Despite using the most common treatment targets including chemotherapy, surgery, radiation, and immunotherapy, natural foods such as fruit and vegetables, generally with biological and antioxidant activities improved their anticancer treatment properties. In this context, many natural foods such as citrus fruits, vegetables, macronutrients, and grains are used to prevent cancer and research and treatment strategies [7, 8]. It seems high consumption of enriched bioactive nutrient components reduces the risk of breast cancer and increases its survival rate [9]. Their mechanisms are involved in various ways consisting of down-regulation of estrogen receptor-alpha (ER-α) [10]. Microalgae contain biological substances such as unsaturated fatty acids, proteins, amino acids, pigments, antioxidants, vitamins, and minerals that are important in the diet, health, biofuels, and healthy products [11]. Among these, Haematococcus Pluvialis (H. pluvialis) is particular importance because of its antioxidant compound called “Astaxanthin”. Astaxanthin is one of the most famous natural pigments that have very strong antioxidant activity and has a great impact on human health, including the prevention of cardiovascular disease, strengthening of immune system, prevention and treatment of various cancers, and the cell aging process prevention [12]. H. pluvialis is one of the important commercial algae and a unicellular freshwater microalga belonging to the class of Chlorophyceae, order Volvocales, and family Haematococcaseae [13]. It is the richest source of astaxanthin (pink carotenoid), nowadays known as a potent antioxidant that is produced by some microalgae, plants, yeasts, and bacteria. Moreover, these algae exist in many kinds of seafood including salmon, shrimp, crab, and fish eggs [12, 14]. Astaxanthin biosynthesis usually occurs under stress conditions such as nutrient shortage, brininess, top temperature, and radiation. The cells of the green alga H.Pluvialis are green flagella in the vegetative stage. In the cystic stage, these cells, when exposed to unfavorable conditions, turn into red cysts that contain a large number of red ketocarotenoids called astaxanthin, which is immobile. When the conditions are right for growth, the cysts germinate to form new motile growth cells [15]. A temperature of 25–28 °C is the most suitable temperature for the growth of different strains of Haematococcus. Previous studies show that the extract of Haematococcus alga inhibits cell cycle progression and cancer cell proliferation and migration in different colon cancer cell lines and induces apoptosis [16]. Moreover, the Hematococcus extract toxicity of alga in lung, breast, and hepatocellular cancers is more than of Dunaliella salina extract [13]. Accordingly, astaxanthin reduces cell proliferation and migration in the breast, [17] gastric, [18]and liver cancers [19]. Different stereoisomers of astaxanthin inhibit cell growth in colon cancer by inhibiting cell line progression and enhancing apoptosis by raising anti-inflammatory effects[20]. It also reduces the incidence of esophageal cancer [21] and increases cell death in oral [22] and liver cancers [19], and it appeare to suppress inflammation in colon cancer [23]. In addition, astaxanthin inhibits the hepatoma cancer cell growth and induces cell apoptosis [24]. The purpose of this study was to evaluate the cytotoxic, apoptotic, and anti-migratory activity of ethanolic extract from H. pluvialis on the MDA-MB-468 cell line. Besides, the expression patterns of Bax, Bcl-2, Caspase 3, Caspase 8, Caspase 9, MMP1, and MMP9 genes were evaluated as candidates in the mentioned pathways.

Materials and Methods

Preparations of H. pluvialis extract (HPE)

The dried biomasses of H. pluvialis were powdered with liquid nitrogen, and 35g of it is poured into 200 ml of the solvent containing 50% water and ethanol, and then were shaken at 80 rpm for 48 hours. Afterward, it was placed in an ultrasonic bath for 20 minutes, passed through a mesh and filter paper, and then centrifuged at 800 rpm for 10 minutes. To purify H. Pluvialis extract, the solvent phase was removed using a vacuum rotary operator, and pure algae powder was obtained. 7 mg of this powder was dissolved in 250 μl of ethanol and then 750 μl of whole culture medium was added to it to be used for the treatment of the desired cell line.

Cell Culture

MDA-MB-468 a breast cancer cell line was purchased from Pasture Institute of Iran. After de-freezing the cells, they were cultured in RPMI-1640 (GIBCO/BRL Life Technologies, USA) medium which was supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA), and 1% antibiotics (100 IU/ml penicillin, 100 μg /ml streptomycin) (Sigma-Aldrich, St. Louis, MO, USA), then incubated at 37°C, with 5% CO2, and 95% humidity. After several passages, the cells were reached the Logarithmic stage and used for different techniques.

MTT assay

MTT assay used to determine the IC50 dose of H. pluvialis. Firstly, the cell suspension was prepared and after cell count, an appropriate number of cells were dissolved in an appropriate amount of complete culture medium. The MDA-MB-468 cells were cultured for 24 hours with an initial concentration of 104 cells in 96-well plates at 200 μl of complete culture medium. The cells were treated with H. plivialis extract in several concentrations (0.5, 1, 2, 4, 8, 16, 25, 32 μl). After 24h incubation period, 50 μl of MTT solution was added to each well, and the plate was further incubated at 37 °C for 4 h. Then, the medium was aspirated and the wells were washed twice with phosphate-buffered saline (PBS). Later, 200 μl of DMSO was added to the wells, and the plate was located on a shaker for 30 min to dissolve the dye. Afterward, the formazan crystals were dissolved, and the absorbance was determined by an ELISA reader (Bio-Tek Instruments) at 570 nm. All the following procedures were done in a sterile area using a Laminar flow cabinet biosafety class II level. In addition, the calculations related to the inhibitor half-concentration(IC50) were calculated with the GraphPad Prism 6.01 (GraphPad Software Inc., San Diego, CA), and the percent cell viability was calculated as follows:

Cell viability %=OD of treatmentOD of control×100

(1)

Apoptosis Assays

After culturing MDA-MB-468 cells at a density of 105 cells/well in six-well plates in 2 mL of serum complete media, the cells were treated by H. pluvialis extract and incubated for 24 and 48 hours with ECC at IC50 (75µg/mL) and higher IC50 (100,150µg/mL) concentrations. The cells were harvested, and adherent cells were detached by 0.25% trypsin-EDTA, then washed with 1 ml of PBS (pH 7.4) and centrifuged. The cells were suspended after adding 200 μg of binding buffer (Invitrogen CO. USA), then FITC-Annexin V reagent was added to the culture plate and incubated on ice for 20 minutes. In the next step, the cells were suspended again for the second time by a binding buffer and 10 μl of propidium iodide (PI) was added.

To evaluate cell death and diagnose early and late apoptosis from necrosis, cells were stained with Annexin V / PI according to the instructions of the Annexin / Propidium Iodide Kit (Biovision, Mountain View, CA, U.S.A.) for flow cytometry tests. Early and late apoptotic/necrotic cells were identified using a BD LSR II cell analyzer (BD Biosciences, San Jose, CA, U.S.A.).

Wound Healing Assay

MDA-MB-468 cells (4×105 cells/well) were cultivated in 6-well plates, and after the cell density of each well reached more than >80%, a scratch was made on the cell layer at the plate surface by the tip of the yellow sampler. PBS (pH 7.4) was used to wash and remove cells isolated from the plate surface. In the next step, the plates were incubated for 72h at 37°C with 5% CO2 to allow cells to migrate from the sides to the wound site. Wound area images were taken at 0, 24, 48, and 72 hours. The rate of migration and the effect of the extract on the inhibition of this phenomenon were evaluated by measuring the width of the gap area.

mRNA Extraction and cDNA Synthesis, and qRT-PCR

The isolation of total RNA was extracted from the treated and untreated cell lines by using the extraction kit (Takara Biotechnology Inc.) according to the manufacturer’s instructions. The quality and quantity of RNA extracted were measured with the NanoDrop 2000c (Thermo Scientific) instrument. For cDNA synthesis, we used 2 μg of total RNA, which was used under the influence of MMLV reverse transcriptase (Takara, cat. No: RR037Q), random hexamer, and oligo dt primers according to the manufacturer’s instructions, and the desired fragment was synthesized. The primers of 8 target genes and, GAPDH were designed by Oligo 7 software and NCBI-BLAST (Table 1). The qRT-PCR reaction was performed with a mix of 10 μl of SYBR green main mixture (Takara, RR820L) mixed with 0.5 μM of each primer, 1 μl of cDNA template and 8 μl of nuclease-free water. Initial stage of enzyme activation at 95°C for 1 minute with 45 cycles at 95°C for 10 seconds, 59 to 63°C for 30 seconds, and 72°C for 20 seconds for different primers Followed. qRT-PCR was performed by the StepOne qRT-PCR system. Finally, the relative expression quantification levels of target genes using the cycle threshold (Ct) values were calculated with the 2-ΔΔCt method [25].

Table 1.

The Primer Sequences

Gene
Bax Forward 5'- GACTCCCCCCGAGAGGTCTT-3'
Reverse 5'- ACAGGGCCTTGAGCACCAGTT-3'
Bcl-2 Forward 5'- GACTCCCCCCGAGAGGTCTT-3'
Reverse 5'- TGCCGGTTCAGGTACTCAGTC-3'
Caspase- 3 Forward 5'- ATGGTTTGAGCCTGAGCAGA-3'
Reverse 5'- GGCAGCATCATCCACACATAC-3'
Caspase- 8 Forward 5'- ACCTTGTGTCTGAGCTGGTCT-3'
Reverse 5'- GCCCACTGGTATTCCTCAGGC-3'

Statistical Methods

Data analysis was presented as the mean ± SD. Differences between the two groups were evaluated by Student’s t-test and one-way ANOVA, respectively. p values <0.05 were considered significant. Data were analyzed using Graph Pad Prism software version 6.01

Results

Anti-proliferative activity of H. pluvialis extract on breast cancer cell

The anti-prolative effects of HPE were assessed using MTT methods. The IC50 values were experimented using twofold dose ranges consisting of 2, 4, 8, 16, 32, and 64 µg. The results were shown the IC50 of the concentrations of 8, 16 (p < 0.05), 32, and 64 µg (p< 0.001) significantly decreased the viability of breast cancer cells compared to control ones (Figure 1).

Figure 1.

Figure 1

Effects of IC50 Concentration of H. pluvialis Extract on MDA-MB-468 Cell Viability: H. pluvialis extract decreased the cell survival to 22.71% compared to the control cells (** p < 0.05) (***p < 0.001).

The effects of H. pluvialis on apoptosis induction

In this study, dual staining of cells with Annexin V / PI was used to quantify the percentage of apoptotic cells. The four areas Q1 to Q4 recorded after analyzing the results by the device software are: Q1 represents (Annexin V- / PI +) in the necrotic cells in the upper left quadrant (UL), Q2 represents late apoptotic cells (Annexin V + / PI +) in the upper right quadrant (UR), Q3 represents primary apoptotic cells (Annexin V + / PI-) in the lower right quadrant (LR), Q4 live cells (Annexin V- / PI-) is shown in the lower left (LL) (Figure 2) (Table 2).

Figure 2.

Figure 2

Flow Cytometry Analysis Indicating the Effect of HPE (H. pluvialis extract) Treatment on the Apoptosis Rate of MDA-MB-468 cells. LL: live cells, LR: early apoptosis, UR: late apoptosis, UL: necrotic cells.

Table 2.

Flow Cytometry Analysis of MDA-MB-468 Cells Treated with H. pluvialis Extract

LL (%) LR(%) UL(%)
Control 98 1.59 0.037
Cases 44.6 50.7 0.27

H. pluvialis extracts prohibits the migration of breast cancer cell

To evaluate the effect of HPE on cell migration of MDA-MB-468, the migration ability of extract-treated cells to fill the wound site was evaluated and compared with the control sample at different time intervals. The results of wound healing are shown in Figure 3. Although the tumor invasion is remarkable in control cells, the H. pluvialis extract inhibited cell migration to the gap area in three-time evaluations.

Figure 3.

Figure 3

The Images from Scratch Healing Rates of the HPE (H. pluvialis extract) treatment effects on tumor cell migration in comparison to normal cell.

The Effects of H. pluvialis extract treatments on the expression of BAX, Bcl-2, MMP-1, MMP-9, Caspase3, Casapese-8, and Caspase 9

The effects of the H. pluvialis extract treatments on the expression of Bcl-2, Caspase 9, Bax, Caspase 3, Caspase 8, MMP-1, and MMP-9 in the MDA-MB-468 cell line were evaluated by qRT-PCR. In the H. pluvialis extracts-treated group, 24 h after treatment, the expression level of Bcl-2 (p =0.002) and MMP-9 (p=0.0413) decreased. Also, after treatment by H. pluvialis extracts, the level of Bax (p =0.004), Caspase 3 (p =0.021), and Caspase 9 (p =0.006) significantly increased (Figure 4). Also, the expression levels of the Cas-8 (p=0.087) and MMP-1 (p =0.14) genes have not significantly changed.

Figure 4.

Figure 4

Effects of HPE (H.pluvialis extract) Treatment on the Gene Expression of BAX, Bcl-2, MMP-1, MMP-9, Caspase 3(Cas-3), Caspase 8 (Cas-8), and Caspase (Cas-9). The data was presented as mean ± SD. *P < 0.05

Discussion

In summary, our findings exhibit that H. pluvialis extract significantly influences the proliferation, migration, and apoptosis pathways in the MDA-MB-468 cell line. It inhibited cell growth in a dose- and time-dependent manner, by arresting cell cycle progression and promoting apoptosis. H. pluvialis extract showed significant inhibitory effects on migration and survival of MDA-MB-468 cell line. The cytotoxicity effect of 8 to 64 μg/ml H. pluvialis extract on cancer cells was significantly different from other concentrations and control samples. In addition, the treated cells with H. Pluvialis extract, cell migration was significantly reduced, which is quite evident in the results of the wound healing test. Moreover, Flow cytometry data confirm the increased incidence of cell apoptosis in H. Pluvialis extract-treated cells compared to the control sample.

Activating or deactivating the expression of genes associated with the apoptotic pathway plays an important role in the control and treatment of many malignancies, especially cancer. In this study, the expression of caspase-9 as a positive indicator of intrinsic apoptosis was significantly increased after treatment with H. Pluvialis extract. However, the increase in caspase-8 expression as a mediator of induction of external apoptosis was not significant in the treated sample compared to the control sample. But the most important member of the caspase family, caspase 3, which is involved in both mitochondrial and external pathways, after treatment with H. Pluvialis extract, its expression has increased significantly. Key genes in the regulation of apoptosis include Bcl-2 and Bax. Accordingly, the expression of the Bcl-2 gene as a negative regulator of apoptosis and Bax as a positive regulator in the treatment and control groups were examined. It was observed that in the treated sample, the expression of both genes was significantly regulated. In addition, MMP-1 and MMP-9 as key members of the matrix metalloproteinase family which play a considerable role in cell migration and metastasis were significantly reduced in the extract-treated sample compared to the control. Elevated MMP-1 expression has been reported in bladder cancer and revealed to be associated with a poor prognosis in these patients [26] as well as in patients with prostate cancer [27], and gastric cancer [28]. The MMP-1 level is also markedly upregulated in breast cancer and stromal cells and is associated with breast cancer progression and poor prognosis [29].

Inhibitory effects of astaxanthin extracted from various sources or synthetic astaxanthin on cancer cell migration and invasion have been reported in different types of human cancers, but for the first time based on our knowledge, it seems the effect of H. pluvialis extracts on the MDA-MB-468 cell line of breast cancer has been studied. This study evaluated the cytotoxic, apoptotic, and anti-migratory activity of extract from H. pluvialis on the MDA-MB-468 cell line.

The growth‐inhibitory effect of the CO2 extract rich in astaxanthin from H. Pluvialis was previously studied by Palozza et al. against HCT116 colon cancer cells [16]. H. pluvialis algae extract inhibits cell growth in a dose- and time-dependent manner by stopping the cell cycle at the G0/G1 phase, and increasing expression levels of P53, P21, CIP, WAF-1, P27 and reducing cyclin D1 expression and AKT phosphorylation [16]. In addition, H. pluvialis algae extract by decreasing BCL2 expression and increasing Bax expression strongly promotes apoptosis [16]. The cytotoxic activity of different fractions of H. pluvialis was investigated on 4 cell lines HePG2, MCF7, HCT116, and A549 by El-Baz et al.; They found that among the various carotenoids contents of the algal extract, Astaxanthin, have the greatest effect on the growth inhibition of HePG2, MCF7, HCT116, and A549 cells [13]. The effects of astaxanthin on proliferation, migration, and gene expression on breast cancer cells including estrogen receptor (ER)+ MCF7 and MDA-MB-231 cells were assessed [17]. It significantly inhibits cell migrations, reduces the number of MDA-MB-231 cells, and induces apoptosis compared to the normal breast epithelial cells (MCF10A), therefore altered gene expression ratios [17]. Moreover, in human gastric cancer cell lines, Astaxanthin through inhibition of ERK phosphorylation and increased p27(kip-1) expression, disturbs cell cycle progression and proliferation [23]

The survival of cancer cells under the influence of Astaxanthin is controlled in a dose-dependent manner. For example, the survival of KATO-III and SNU-1 cancer cell lines was suppressed by Astaxanthin in a dose-dependent manner with a significant reduction in proliferation. Astaxanthin increased the number of cells in the G0/G1 phase [20] but redused the proportion of the S phase in both cells [18]. Different stereoisomers of astaxanthin inhibit cell growth in colon cancer by inhibiting cell line progression and enhancing apoptosis by raising anti-inflammatory effects by inducing G2/M cell cycle arrest [20]. Flow cytometry analysis indicated that astaxanthin induced G2/M cell cycle arrest and cellular apoptosis in cancer cells. The cell cycle arrest caused by astaxanthin was associated with increases in the expression levels of p21Cip1/Waf1, p27, and p53, as well as decreases in the levels of CDK4 and CDK6 [20].

In summary, H. pluvialis intervention significantly and dose-dependently (32 and 64 µg) decreased the viability of breast cancer cells. Its intervention promotes cell apoptosis and significantly inhibits cell migration. In this way, the related biomarkers displayed significant upregulated expression levels of Caspase 3 and Caspase 9 and downregulated levels of Bcl-2 and Bax. Therefore, H.pluvialis extract may be an effective anticancer that developed cytotoxic properties.

In conclusion, in the current research, we found that H. pluvialis extraction significantly and dose-dependently promotes apoptosis and decreases the viability of breast cancer cells.

Author Contribution Statement

All authors contributed equally in this study.

Acknowledgements

The authors are thankful from patients and their families for their contribution in the study. This study was financially supported by a grant from Department of Tuberculosis and Lung Diseases Research Center, University Tabriz University of Medical Sciences, Tabriz, Iran.

Funding

This study was supported by a grant from research deputy of Department of Tuberculosis and Lung Diseases Research Center, University Tabriz University of Medical Sciences, Tabriz, Iran.

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request

Ethical approval

All procedures performed in were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Conflict of Interest Statement

The authors declare no potential conflict of interest.

References

  • 1.Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 world health organization classification of tumours of the breast. Histopathology. 2020;77(2):181–5. doi: 10.1111/his.14091. [DOI] [PubMed] [Google Scholar]
  • 2.Shanehbandi D, Zarredar H, Asadi M, Zafari V, Esmaeili S, Seyedrezazadeh E, et al. Anticancer impacts of terminalia catappa extract on sw480 colorectal neoplasm cell line. J Gastrointest Cancer. 2019;52(1):99–105. doi: 10.1007/s12029-019-00349-z. [DOI] [PubMed] [Google Scholar]
  • 3.Zendehdel K. Cancer statistics in IR Iran in 2018. Basic & clinical cancer research. 2019 ;11(1):1–4. [Google Scholar]
  • 4.Dieterich M, Stubert J, Reimer T, Erickson N, Berling A. Influence of lifestyle factors on breast cancer risk. Breast Care (Basel) 2014;9(6):407–14. doi: 10.1159/000369571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B, et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24(4):549–53. doi: 10.26444/aaem/75943. [DOI] [PubMed] [Google Scholar]
  • 6.Godet I, Gilkes DM. Brca1 and brca2 mutations and treatment strategies for breast cancer. Integr cancer sci ther. 2017;4:1. doi: 10.15761/ICST.1000228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Majolo F, Delwing LK, Marmitt DJ, Bustamante-Filho IC, Goettert MI. Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery. Phytochemistry Letters. 2019;31:196–207. [Google Scholar]
  • 8.Barzegari A, Saeedi N, Zarredar H, Barar J, Omidi Y. The search for a promising cell factory system for production of edible vaccine: Spirulina as a robust alternate to plants. Hum Vaccin Immunother. 2014;10(8):2497–502. doi: 10.4161/hv.29032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Li Y, Li S, Meng X, Gan RY, Zhang JJ, Li HB. Dietary natural products for prevention and treatment of breast cancer. Nutrients. 2017;9:7. doi: 10.3390/nu9070728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sathasivam R, Radhakrishnan R, Hashem A, Abd_Allah EF. Microalgae metabolites: A rich source for food and medicine. Saudi J Biol Sci. 2019;26(4):709–22. doi: 10.1016/j.sjbs.2017.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Christaki E. Microalgae: A novel ingredient in nutrition. Int J Food Sci Nutr. 2011;62(8):794–9. doi: 10.3109/09637486.2011.582460. [DOI] [PubMed] [Google Scholar]
  • 12.Ambati RR. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications—a review. Mar drugs. 2014;1(128-152) doi: 10.3390/md12010128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.El‐Baz FK, Hussein RA, Mahmoud K, Abdo SM. Cytotoxic activity of carotenoid rich fractions from haematococcus pluvialis and dunaliella salina microalgae and the identification of the phytoconstituents using lc‐dad/esi‐ms. Phytother Res. 2018;32(2):298–304. doi: 10.1002/ptr.5976. [DOI] [PubMed] [Google Scholar]
  • 14.Stachowiak B, Szulc P. Astaxanthin for the food industry. Molecules. 2021;26(9):2666. doi: 10.3390/molecules26092666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Li F, Cai M, Lin M, Huang X, Wang J, Ke H, et al. Differences between motile and nonmotile cells of haematococcus pluvialis in the production of astaxanthin at different light intensities. Mar drugs. 2019;17(1):39. doi: 10.3390/md17010039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Palozza P, Torelli C, Boninsegna A, Simone R, Catalano A, Mele MC, et al. Growth-inhibitory effects of the astaxanthin-rich alga haematococcus pluvialis in human colon cancer cells. Cancer lett. 2009;283(1):108–17. doi: 10.1016/j.canlet.2009.03.031. [DOI] [PubMed] [Google Scholar]
  • 17.McCall B, McPartland C, Moore R, Frank-Kamenetskii A, Booth B. Effects of astaxanthin on the proliferation and migration of breast cancer cells in vitro. Antioxidants. 2018;7(10):135. doi: 10.3390/antiox7100135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kim JH, Park JJ, Lee BJ, Joo MK, Chun HJ, Lee SW, et al. Astaxanthin inhibits proliferation of human gastric cancer cell lines by interrupting cell cycle progression. Gut and liver. 2016;10(3):369. doi: 10.5009/gnl15208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shao Y, Ni Y, Yang J, Lin X, Li J, Zhang L. Astaxanthin inhibits proliferation and induces apoptosis and cell cycle arrest of mice h22 hepatoma cells. Med Sci Monit. 2016;22:2152. doi: 10.12659/MSM.899419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu X, Song M, Gao Z, Cai X, Dixon W, Chen X, et al. Stereoisomers of astaxanthin inhibit human colon cancer cell growth by inducing g2/m cell cycle arrest and apoptosis. J Agric Food Chem. 2016;64(41):7750–9. doi: 10.1021/acs.jafc.6b03636. [DOI] [PubMed] [Google Scholar]
  • 21.Cui L, Xu F, Wang M, Li L, Qiao T, Cui H, et al. Dietary natural astaxanthin at an early stage inhibits n-nitrosomethylbenzylamine–induced esophageal cancer oxidative stress and inflammation via downregulation of nfκb and cox2 in f344 rats. Onco Targets Ther. 2019;12:5087. doi: 10.2147/OTT.S197044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kavitha K, Kowshik J, Kishore TK, Baba AB, Nagini S. Kranthi Kiran Kishore, Abdul Basit Baba, and S Nagin Astaxanthin inhibits nf-κb and wnt/β-catenin signaling pathways via inactivation of erk/mapk and pi3k/akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim Biophys Acta. 2013;1830(10):4433–44. doi: 10.1016/j.bbagen.2013.05.032. [DOI] [PubMed] [Google Scholar]
  • 23.Kim HY, Kim YM, Hong S. Astaxanthin suppresses the metastasis of colon cancer by inhibiting the myc-mediated downregulation of microrna-29a-3p and microrna-200a. Sci rep. 2019;9(1):1–10. doi: 10.1038/s41598-019-45924-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nagaraj S, Rajaram MG, Arulmurugan P, Baskaraboopathy A, Karuppasamy K, Jayappriyan KR, et al. Antiproliferative potential of astaxanthin-rich alga Haematococcus pluvialis Flotow on human hepatic cancer (HepG2) cell line. Biomedicine & Preventive Nutrition. 2012;2(3):149–53. [Google Scholar]
  • 25.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative pcr and the 2− δδct method. methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 26.Shin DH, Dier U, Melendez JA, Hempel N. Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2015;1852(12):2593–602. doi: 10.1016/j.bbadis.2015.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ozden F, Saygin C, Uzunaslan D, Onal B, Durak H, Aki H. Expression of mmp-1, mmp-9 and timp-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol. 2013;139(8):1373–82. doi: 10.1007/s00432-013-1453-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cai Q-W, Jun Li, Li XQ, Wang JQ, Huang Y. Expression of stat3, mmp-1 and timp-1 in gastric cancer and correlation with pathological features. Mol med rep. 2012;5(6):1438–42. doi: 10.3892/mmr.2012.849. [DOI] [PubMed] [Google Scholar]
  • 29.Wang QM, Li Lv, Tang Y, Li Zhang, LiFen Wang. Mmp1 is overexpressed in triplenegative breast cancer tissues and the knockdown of mmp1 expression inhibits tumor cell malignant behaviors in vitro. Oncol lett. 2019;17(2):1732–40. doi: 10.3892/ol.2018.9779. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request


Articles from Asian Pacific Journal of Cancer Prevention : APJCP are provided here courtesy of West Asia Organization for Cancer Prevention

RESOURCES